Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, raised an additional $15.5 million in Series...
Nuclera’s $15.5 Million Additional Capital Raise
Nuclera’s Series B Funding Round
Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, thorugh its Series B financing, raised a...
Nuclera’s Acquisition of Digital Microfluids Unit from E Ink
Sullivan & Worcester advised E Ink on the deal. Taylor Wessing advised Nuclera. E Ink, the leading innovator of electronic ink technology, announced the sale of its...